Nucleic acid detection

• US 6,312,902 B1
• Filed: 09/27/1999
• Issued: 11/06/2001
• Est. Priority Date: 03/13/1998
• Status: Expired due to Fees

• Current Assignee: Promega Corporation
• Original Assignee: Promega Corporation
• Inventors: Olson, Ryan J., Hartnett, James Robert, Gu, Trent, Mandrekar, Michelle, Rhodes, Richard Byron, Lewis, Martin K., Kephart, Daniel, Leippe, Donna, Shultz, John William, Andrews, Christine Ann, Welch, Roy
• Primary Examiner(s): Fredman, Jeffrey
• Assistant Examiner(s): CHAKRABARTI, ARUN K
• Application Number:
  US09/406,065
• Time in Patent Office: 771 Days
• Field of Search: 435/6, 435/91.2, 435/91.5, 435/7, 436/173, 436/501, 536/26, 536/27, 536/28, 935/77, 935/82
• US Class Current: 435/6.11
• CPC Class Codes: C12Q 1/04 Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor C12Q1/6897 takes precedence
• CPC Class Codes: C12Q 1/66 involving luciferase
• CPC Class Codes: C12Q 1/68 involving nucleic acids
• CPC Class Codes: C12Q 1/6823 Release of bound markers
• CPC Class Codes: C12Q 1/6827 for detection of mutation or polymorphism
• CPC Class Codes: C12Q 2521/319 Exonuclease
• CPC Class Codes: C12Q 2535/107 Maxam and Gilbert method, i.e. sequential release and detection of nucleotides
• CPC Class Codes: C12Q 2535/131 Allele specific probes
• CPC Class Codes: C12Q 2537/101 Homogeneous assay format, e.g. one pot reaction
• CPC Class Codes: C12Q 2565/1015 labels being on the same oligonucleotide
• CPC Class Codes: C12Q 2565/301 Pyrophosphate (PPi)
• CPC Class Codes: C12Q 2565/627 being a mass spectrometer
• CPC Class Codes: Y10T 436/24 Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry

Abstract

Processes are disclosed using the depolymerization of a nucleic acid hybrid to qualitatively and quantitatively analyze for the presence of a predetermined nucleic acid. Applications of those processes include the detection of single nucleotide polymorphisms, identification of single base changes, speciation, determination of viral load, genotyping, medical marker diagnostics, and the like.

Claims

1. A method for enhancing the discrimination of analytical output in the determination of the presence or absence of a predetermined target nucleic acid sequence in a nucleic acid sample that comprises the steps of:

(A) providing a plurality of separate treated samples, each sample containing (a) a nucleic acid that may contain said predetermined nucleic acid target sequence, said nucleic acid target sequence being hybridized when present with (b) a nucleic acid probe,

a first probe of a first treated sample comprising (i) a 3′

-terminal region sequence that is complementary to said nucleic acid target sequence and includes an identifier nucleotide that is complementary to a first predetermined nucleotide of said nucleic acid target sequence and (ii) a second sequence otherwise complementary to said nucleic acid target sequence except for a second predetermined nucleotide located 2 to about 10 nucleotides upstream from the 3′

-terminus of said probe that is not complementary to a second nucleotide of said nucleic acid target sequence, and

a second probe of a second treated sample comprising (i) a 3′

-terminal sequence that is complementary to said nucleic acid target sequence except for an identifier nucleotide that is not complementary to said first-named predetermined nucleotide of said nucleic acid target sequence and (ii) a second sequence otherwise complementary to said nucleic acid target sequence except for said second predetermined nucleotide located 3 to about 10 nucleotides upstream from the 3′

-terminus of said probe that is not complementary to a second predetermined nucleotide of said nucleic acid target sequence;

(B) admixing each treated sample with a depolymerizing amount of an enzyme whose activity is to release one or more nucleotides from the 3′

-terminus of a hybridized nucleic acid probe to form a treated reaction mixture, wherein said enzyme catalyzes pyrophosphorolysis;

(C) maintaining the treated reaction mixtures for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid probe and release an identifier nucleotide; and

(D) analyzing the samples for the presence of released identifier nucleotide to obtain an analytical output, the ratio of the analytical output from the sample containing the first probe relative to that of the second probe being enhanced compared to the ratio of the analytical output from a similar sample containing a third probe of the same length having the same identifier nucleotide and total complementarity to said nucleic acid target sequence relative to that of a fourth probe of the same length whose identifier nucleotide is non-complementary to said first predetermined nucleotide and is otherwise totally complementary to said target nucleic acid sequence.

2. The method according to claim 1 wherein said identifier nucleotide is a nucleoside triphosphate.

3. The method according to claim 1 wherein said analytical output is obtained by luminescence spectroscopy.

4. The method according to claim 1 wherein said analytical output is obtained by fluorescence spectroscopy.

5. The method according to claim 1 wherein said analytical output is obtained by mass spectrometry.

6. The method according to claim 1 wherein said analytical output is obtained by absorbance spectroscopy.

7. The method according to claim 1 including the further steps of forming said first and second treated samples by

(A) separately admixing a sample to be assayed with each of said first and second nucleic acid probes to form separate hybridization compositions, wherein the 3′ -terminal region of said nucleic acid probes (a) hybridize with partial or total complementarity to said nucleic acid target sequence when that sequence is present in the sample and (b) include an identifier nucleotide;

(B) maintaining said hybridization compositions for a time period sufficient to form treated samples that may contain said one predetermined nucleic acid target sequence hybridized with said nucleic acid probes.

8. The method according to claim 1 wherein said nucleic acid sample is obtained from a biological sample.

9. The method according to claim 2 wherein said nucleoside triphosphate is used to covert ADP to ATP using NDPK.

10. The method according to claim 9 wherein said NDPK is encoded by Pyrococcus furiosis.

11. The method of claim 1 wherein said enzyme whose activity is to release one or more nucleotides from the 3′

-terminus of a hybridized nucleic acid probe is a thermostable DNA polymerase.

12. A method for decreasing background signal in an assay to detect the presence or absence of predetermined nucleic acid target sequence in a nucleic acid sample that comprises the steps of:

(A) admixing a sample to be assayed with a pair of amplifying primers to form an extension composition in which said amplifying primers are hybridized to said nucleic acid target sequence when said target sequence is present, and wherein one of said pair of amplifying primers contains a 5′

-terminus containing a plurality of nucleotide linkages resistant to cleavage by T7 gene 6 exonuclease or T3 gene 6 exonuclease or λ

exonuclease;

(B) reacting the extension composition with a polymerase and nucleotides to extend the amplifying primers to form nucleic acid strands when the predetermined nucleic acid target sequence is present in the extension composition and form a treated extension composition;

(C) admixing said treated extension composition with T7 gene 6 exonuclease or T3 gene 6 exonuclease or λ

exonuclease to form a strand removal composition;

(D) maintaining the strand removal composition for a time period sufficient to substantially degrade hybridized nucleic acid strands not resistant to cleavage by T7 gene 6 exonuclease or T3 gene 6 exonuclease or λ

exonuclease to form a treated sample;

(E) admixing said treated sample with a nucleic acid probe that hybridizes with said extended amplifying primer and includes an identifier nucleotide in the 3′

-terminal region to form second hybrids;

(F) admixing the second hybrids with a depolymerizing amount of an enzyme whose activity is to release one or more nucleotides from the 3′

-terminus of a hybridized nucleic acid probe to form a treated reaction mixture, wherein said enzyme catalyzes pyrophosphorolysis;

(G) maintaining the treated reaction mixture for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid and release identifier nucleotides therefrom; and

(H) analyzing for the presence of released identifier nucleotides to obtain an analytical output, the analytical output indicating the presence or absence of said nucleic acid target sequence.

13. The method according to claim 12 wherein the plurality of amplifying primer 5′

-terminal linkages resistant to 5′

to 3′

exonuclease activity are phosphorothioate linkages.

14. The method according to claim 12 wherein the 5′

-terminus of said amplifying primer contains two or three linkages resistant to the activity of said 5′

to 3′

-exonucleases.

15. The method according to claim 14 wherein the 5′

-terminus of said amplifying primer contains two or three phosphorothioate linkages.

16. The method according to claim 12 wherein said identifier nucleotide is a nucleoside triphosphate.

17. The method according to claim 12 wherein said analytical output is obtained by luminescence spectroscopy.

18. The method according to claim 12 wherein said analytical output is obtained by fluorescence spectroscopy.

19. The method according to claim 12 wherein said analytical output is obtained by mass spectrometry.

20. The method according to claim 12 wherein said analytical output is obtained by absorbance spectroscopy.

21. The method according to claim 12 wherein said nucleic acid sample is obtained from a biological sample.

22. The method according to claim 16 wherein said nucleoside triphosphate is used to covert ADP to ATP using NDPK.

23. The method according to claim 22 wherein said NDPK is encoded by Pyrococcus furiosis.

24. The method of claim 12 wherein said enzyme whose activity is to release one or more nucleotides from the 3′

-terminus of a hybridized nucleic acid probe is a thermostable polymerase.

25. The method of claim 12 wherein said a plurality of different primer pairs is admixed with said sample to be assayed, said primers being hybridized to a plurality of target nucleic acid sequences when those target sequences are present in said sample.

26. A process to determine the presence or absence of a predetermined single-stranded nucleic acid target sequence comprising the steps of:

(A) providing a depolymerization reaction mixture comprising (a) a pair of first and second complementary nucleic acid probes that form 3′

-overhangs on both ends of the duplex formed when each of said pair of complementary nucleic acid probes is hybridized with the other, the first of said probes being complementary to the nucleic acid target sequence, (b) a hybrid between a third probe and the nucleic acid target sequence when the nucleic acid target sequence is present in the nucleic acid sample, and (c) a depolymerizing amount of an enzyme whose activity is to release nucleotides from the 3′

-terminus of a hybridized nucleic acid wherein said enzyme catalyzes pyrophosphorolysis, wherein each of said first and third probes has an identifier nucleotide in its 3′

-terminal region;

(B) maintaining the depolymerization reaction mixture for a time period sufficient to permit the enzyme to depolymerize the 3′

-terminal region of said hybridized third probe to release identifier nucleotide and form a first treated reaction mixture;

(C) denaturing the products of the first treated reaction mixture to form a denatured treated reaction mixture;

(D) maintaining the denatured treated reaction mixture for a time period sufficient to form a second depolymerization reaction mixture that comprises (a) a hybrid formed between said first probe and said nucleic acid target sequence when the nucleic acid target sequence is present in the nucleic acid sample and (b) a hybrid formed between the 3′

-terminal-depolymerized third probe and said second nucleic acid probe, one end of said hybrid having a blunt end or a 5′

-overhang as well as an identifier nucleotide in the 3′

-terminal region;

(E) depolymerizing hybrids (a) and (b) of step (D) to release identifier nucleotide from the 3′

-terminal regions of said hybrids to form a second treated reaction mixture; and

(F) analyzing said second treated reaction mixture for the presence of released identifier nucleotide to obtain an analytical output, the analytical output indicating the presence or absence of said nucleic acid target sequence.

27. The process according to claim 26 wherein said first and third probes are the same.

28. The method according to claim 26 wherein said identifier nucleotide is a nucleoside triphosphate.

29. The method according to claim 26 wherein said analytical output is obtained by luminescence spectroscopy.

30. The method according to claim 26 wherein said analytical output is obtained by fluorescence spectroscopy.

31. The method according to claim 26 wherein said analytical output is obtained by mass spectrometry.

32. The method according to claim 26 wherein said analytical output is obtained by absorbance spectroscopy.

33. The method according to claim 26 wherein said nucleic acid sample is obtained from a biological sample.

34. The method according to claim 28 wherein said nucleoside triphosphate is used to covert ADP to ATP using NDPK.

35. The method according to claim 34 wherein said NDPK is encoded by Pyrococcus furiosis.

36. The method of claim 26 wherein said enzyme whose activity is to release one or more nucleotides from the 3′

-terminus of a hybridized nucleic acid probe is a thermostable polymerase.

37. A process to determine the presence or absence of a predetermined double-stranded nucleic acid target sequence comprising the following steps:

(A) providing a first reaction mixture comprising (a) first and second complementary nucleic acid probes that form 3′

-overhangs on both ends of the duplex formed when each of said complementary nucleic acid probes is hybridized with the other, wherein said each of probes is complementary to one or the other strand of the nucleic acid target sequence and has an identifier nucleotide in its 3′

-terminal region, (b) hybrids between a third and fourth probe and each of the two strands of the nucleic acid target sequence when the nucleic acid target sequence is present in the nucleic acid sample, said third and fourth probes each having an identifier nucleotide in its 3′

-terminal region and (c) a depolymerizing amount of an enzyme whose activity is to release nucleotides from the 3′

-terminus of a hybridized nucleic acid, wherein said enzyme catalyzes pyrophosphorolysis;

(B) maintaining the first reaction mixture for a time period sufficient to permit the enzyme to depolymerize hybridized nucleic acid to release identifier nucleotide from the 3′

-terminal region of said hybridized third and fourth probes and form a treated first reaction mixture;

(C) denaturing the products of the treated first reaction mixture to form a denatured treated reaction mixture;

(D) maintaining the denatured treated reaction mixture for a time period sufficient to form a second reaction mixture that comprises a (a) hybrids that lack a 3′

-overhang between each of the strands of the target nucleic acid and each of the first and second probes when the nucleic acid target sequence is present in the nucleic acid sample, and (b) hybrids between each of the first and seconds probes and 3′

-terminal region-depolymerized third and fourth probes, wherein each of said hybrids comprises one end that is blunt or has a 5′

-overhang as well as an identifier nucleotide in the 3′

-terminal region; and

(E) depolymerizing the hybrids (a) and (b) of step (D) to release identifier nucleotide from the 3′

-terminus of said hybridized probes to form a second treated reaction mixture; and

(F) analyzing said second treated reaction mixture for the presence of released identifier nucleotide to obtain an analytical output, the analytical output indicating the presence or absence of said nucleic acid target sequence.

38. The process according to claim 37 wherein said first and third probes are the same.

39. The process according to claim 37 wherein steps A through D are repeated prior to conducting step E.

40. The method according to claim 37 wherein said identifier nucleotide is a nucleoside triphosphate.

41. The method according to claim 37 wherein said analytical output is obtained by luminescence spectroscopy.

42. The method according to claim 37 wherein said analytical output is obtained by fluorescence spectroscopy.

43. The method according to claim 37 wherein said analytical output is obtained by mass spectrometry.

44. The method according to claim 37 wherein said analytical output is obtained by absorbance spectroscopy.

45. The method according to claim 37 wherein said nucleic acid sample is obtained from a biological sample.

46. The method according to claim 40 wherein said nucleoside triphosphate is used o covert ADP to ATP using NDPK.

47. The method according to claim 46 wherein said NDPK is encoded by Pyrococcus furiosis.

48. The method of claim 37 wherein said enzyme whose activity is to release one or more nucleotides from the 3′

-terminus of a hybridized nucleic acid probe is a thermostable polymerase.